Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice

Journal of General Virology

Volumn 89, Issue 6, 2008, Pages 1533-1544

  Song, Chang Hyun ^a   Furuoka, Hidefumi ^b   Kim, Chan Lan ^a,c   Ogino, Michiko ^a,d   Suzuki, Akio ^a   Hasebe, Rie ^a   Horiuchi, Motohiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN ANTIBODY; PRION PROTEIN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GENETIC VARIABILITY; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOTHERAPY; MICROGLIA; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STRAIN DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; THALAMUS; TREATMENT DURATION; VIRUS STRAIN; ANIMAL; ASTROCYTE; DRUG ADMINISTRATION; DRUG SCREENING; GLIOSIS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PRION; SCRAPIE;

ANIMALIA; MUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ASTROCYTES; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; FEMALE; GLIOSIS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED ICR; MICROGLIA; PRIONS; PRPSC PROTEINS; SCRAPIE; THALAMUS;

EID: 45949096622     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83578-0     Document Type: Article

References (47)

1. Bate, C., Reid, S. & Williams, A. (2001). Killing of prion-damaged neurones by microglia. Neuroreport 12, 2589-2594.
2. Bate, C., Boshuizen, R. S., Langeveld, J. P. & Williams, A. (2002). Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation. Neuroreport 13, 1695-1700.
3. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C. & Aguzzi, A. (1996). Normal host prion protein necessary for scrapic-induced neurotoxicity. Nature 379, 339-343.
4. Check E. (2002). Nerve inflammation halts trial for Alzheimer's drug. Nature 415, 462.
5. Chesebro, B., Race, R. & Kercher, L. (2005). Scrapic pathogencsis in brain and retina: effects of prion protein expression in neurons and astrocytes. J Neurovirol 11, 476-480.
6. Demaimay, R., Adjou, K. T., Beringue, V., Demart S., Lasmézas, C. I., Deslys, J. P., Seman, M. & Dormont, D. (1997). Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J Virol 71, 9685-9689.
7. Doh-ura, K., Ishikawa, K., Murakami-Kubo, I., Sasaki, K., Mohri, S., Race, R. & Iwaki, T. (2004). Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 78, 4999-5006.
8. Donofrio, G., Heppner, F. L., Polymenidou, M., Musahl, C. & Aguzzi, A. (2005). Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J Virol 79, 8330-8338.
9. Ehlers, B. & Diringer, H. (1984). Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol 65, 1325-1330.
10. El Khoury, J., Tolt, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C. & Luster, A. D. (2007). Ccr2 deficiency impairs microgbal accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13, 432-438.
11. Enari, M., Flechsig, E. & Weissmann, C. (2001). Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 98, 9295-9299.
12. Farquhar, C. F. & Dickinson, & G. (1986). Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J Gen Virol 67, 463-473.
13. Sc replication in infected cells. J Biol Chem 280, 11247-11258.
14. Fernandez-Borges, N., Brun, A., Whitton, J. L., Parra, B., Diaz-San Segundo, F., Salguero, F. J., Torres, J. M. & Rodriguez, F. (2006). DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J Virol 80, 9970-9976.
15. Furuoka, H., Yabuzoe, A., Horiuchi, M., Tagawa, Y., Yokoyama, T., Yamakawa, Y., Shinagawa, M. & Sata, T. (2005). Effective antigen-retrieval method for immunohistochemical detection of abnormal isoform of prion proteins in animals. Acta Neuropathol 109, 263-271.
16. Sc propagation in prion-infected cells. J Biol Chem 278, 18524-18531.
17. Goñi, F., Knudsen, E., Schreiber, F., Scholtzova, H., Pankiewicz, J., Carp, R., Meeker, H. C., Rubenstein, R., Brown, D. R. & other authors (2005). Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 133, 413-421.
18. Heppner, F. L., Musahl, C., Arrighi, I., Klein, M. A., Rülicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U. & Aguzzi, A. (2001). Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182.
19. Horiuchi, M. & Caughey, B. (1999). Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 18, 3193-3203.
20. C) exists in many non-neuronal tissues of sheep. J Gen Virol 76, 2583-2587.
21. Horiuchi, M., Mochizuki, M., Ishiguro, N., Nagasawa, H. & Shinagawa, M. (1997). Epitope mapping of a monoclonal antibody specific to feline panleukopenia virus and mink enteritis virus. J Vel Med Sci 59, 133-136.
22. Kaneko, K., Peretz, D., Pan, K. M., Blochberger, T. C., Wille, H., Gabizon, R., Griffith, O. H., Cohen, F. E., Baldwin, M. A. & Prusiner, S. B. (1995). Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Sci U S A 92, 11160-11164.
23. Kim, C. L., Umetani, A., Matsui, T., Ishiguro, N., Shinagawa, M. & Horiuchi, M. (2004a). Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 320, 40-51.
24. C by anti-PrP antibody prevents protease-resistant PrP formation. J Gen Virol 85, 3473-3482.
25. Kocisko, D. A., Caughey, W. S., Race, R. E., Roper, G., Caughey, B. & Morrey, J. D. (2006). A porphyrin increases survival time of mice after intracerebral prion infection. Antimicrob Agents Chemother 50, 759-61.
26. Kuwata, K., Nishida, N., Matsumoto, T., Kamatari, Y. O., Hosokawa-Muto, J., Kodama, K., Nakamura, H. K., Kimura, K., Kawasaki, M. & other authors (2007). Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci U S A 104, 11921-11926.
27. Ladogana, k, Casaccia, P., Ingrosso, L., Cibati, M., Salvatore, M., Xi, Y. G., Masullo, C. & Pocchiari, M. (1992). Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol 73, 661-665.
28. Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P. C., Brandner, S. & Collinge, J. (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874.
29. Marella, M., Gaggioli, C., Batoz, M., Deckert, M, Tartare-Deckert, S. & Chabry, J. (2005). Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment. J Biol Chem 280, 1529-1534.
30. C helix 1 in the hydrophilic seeding of prion aggregates. Proc Natl Acad Sci U S A 96, 11293-11298.
31. Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. & Weller, R. O. (2003). Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 9, 448-452.
32. Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B, Eisner, L. & other authors (2003). Subacute meningoencephalitis in a subset of patients With AD after Aβ42 immunization. Neurology 61, 46-54.
33. Paxinos, G. & Franklin, K. B. J. (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego: Academic Press.
34. Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulm, G., Mehlhorn, I. R., Legname, G., Wormald, M. R. & other authors (2001). Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743.
35. C degradation. J Neurochem 89, 454-463.
36. Priola, S. A., Raines, A. & Caughey, W. S. (2000). Porphyrin and phthalocyanine antiscrapie compounds. Science 287, 1503-1506.
37. Rainov, N. G., Tsuboi, Y, Krolak-Salmon, P., Vighetto, A. & Doh-Ura, K. (2007). Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate? Expert Opin Biol Ther 7, 713-726.
38. Sadowski, M. & Wisniewski, T. (2004). Vaccines for conformational disorders. Expert Rev Vaccines 3, 279-290.
39. Schenk. D. (2002). Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nat Rev Neurosci 3, 824-828.
40. Schwarz, A., Kr)dsatke, O., Burwinkel, M., Riemer, C., Schultz, J., Henklein, P., Bamme, T. & Baier, M. (2003). Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett 350, 187-189.
41. Sigurdsson, E. M., Brown, D. R., Daniels, M., Kascsak, R. J., Kascsak, R., Carp, P, Meeker, H. C., Frangione, B. & Wisniewski, T. (2002). Immunization delays the onset of prion disease in mice. Am J Pathol 161, 13-17.
42. Solforosi, L., Criado, J. R., McGavern, D. B., Wirz, S., Sanchez-Alavez, M., Sugama, S., DeGiorgio, L. A., Volpe, B. T., Wiseman, E. & other authors (2004). Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514-1516.
43. Speare, J. O., Rush, T. S., III, Bloom, M. E. & Caughey, B. (2003). The role of helix 1 aspartates and salt bridges in the stability and conversion of prion protein. J Biol Chem 278, 12522-12529.
44. Todd, N. V., Morrow, J., Doh-ura, K, Dealler, S., O'Hare, S., Farling, P., Duddy, M. & Rainov, N. G. (2005). Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-jakob disease. J Infect 50, 394-396.
45. Trevitt, C. R. & Collinge, J. (2006). A systematic review of prion therapeutics in experimental models. Brain 129, 2241-2265.
46. Uryu, M, Karino, A., Kamihara, Y. & Horiuchi, M. (2007). Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones. Microbiol Immunol 51, 661-667.
47. White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J. & Hawke, S. (2003). Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80-83.